Advancing today’s therapies to enable healthier lives
We are transforming patient care by developing innovative medicines that address significant unmet patient needs in high-value markets
Proprietary portfolio
Using our Arestat® technology platform, we are developing enhanced therapeutic medicines for the treatment of diabetes and obesity
Partnering
We are partnering with leading pharmaceutical and medtech companies to develop enhanced therapeutic medicines
Validated technology
A business underpinned by the world-leading Arestat® technology platform with a robust intellectual property portfolio
Latest News
-
4th September 2025
Arecor announces positive FDA feedback on Phase 2 clinical study design for AT278 in an AID system
-
14th July 2025
ARECOR ESTABLISHES NEW SCIENTIFIC ADVISORY BOARD OF WORLD LEADING EXPERTS IN ORAL DRUG DELIVERY
-
19th May 2025
ARECOR ESTABLISHES PARTNERSHIP WITH SKYE BIOSCIENCE TO DEVELOP ENHANCED FORMULATION OF OBESITY CANDIDATE NIMACIMAB